Search

Author/Creator Cook, Jack A.

1. Exposure‐Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies. Issue 1 (27th April 2022)

Authors:
Mukherjee, Arnab; Tsuchiwata, Shinichi; Nicholas, Timothy; Cook, Jack A.; Modesto, Irene; Su, Chinyu; D'Haens, Geert R.; Sandborn, William J.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 1(2022)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ITC Commentary on Metformin Clinical Drug–Drug Interaction Study Design That Enables an Efficacy‐ and Safety‐Based Dose Adjustment Decision. Issue 5 (15th May 2018)

Authors:
Zamek‐Gliszczynski, Maciej J.; Chu, Xiaoyan; Cook, Jack A.; Custodio, Joseph M.; Galetin, Aleksandra; Giacomini, Kathleen M.; Lee, Caroline A.; Paine, Mary F.; Ray, Adrian S.; Ware, Joseph A.; Wittwer, Matthias B.; Zhang, Lei
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 104:Issue 5(2018)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product Performance. Issue 11 (24th September 2014)

Authors:
Selen, Arzu; Dickinson, Paul A.; Müllertz, Anette; Crison, John R.; Mistry, Hitesh B.; Cruañes, Maria T.; Martinez, Marilyn N.; Lennernäs, Hans; Wigal, Tim L.; Swinney, David C.; Polli, James E.; Serajuddin, Abu T. M.; Cook, Jack A.; Dressman, Jennifer B.
Journal:
Journal of pharmaceutical sciences
Issue:
Volume 103:Issue 11(2014:Nov.)
Page Start:
3377
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗